
Revolutionary Bluetongue Vaccine Slashes Cattle Dose by 50%!
2025-07-16
Author: Yu
Groundbreaking Approval for Bluetongue Vaccine
In an exciting development for livestock health, Virbac has unveiled its innovative Bluetongue vaccine, Syvazul BTV 3, now authorized for use in Great Britain! This game-changer not only targets cattle but also sheep, featuring a significantly reduced dosage for bovines.
Half the Dose, Double the Convenience!
Say goodbye to cumbersome vaccinations! The new formulation reduces the recommended dose for cattle from 4 ml to just 2 ml, streamlining the immunization process and complying with the latest regulatory standards.
Immunity Onset and Dosage Details
The vaccine is designed to actively immunize cattle against the deadly Bluetongue virus type 3 (BTV-3), drastically minimizing viraemia. After receiving both doses of 2 ml each, spaced 3 weeks apart, cattle can expect immunity to kick in within just 3 weeks.
Administering the Vaccine: What You Need to Know
This vaccine isn’t just for mature cattle! It can be administered to naive calves from 2 months old or from 3 months for those born to immune mothers. For sheep, the vaccination protocol is also straightforward—one 2 ml subcutaneous dose for animals 3 months or older, offering protection within 4 weeks.
A Win for Farmers and Animal Welfare!
This new authorization not only enhances convenience for farmers but also ensures better health outcomes for both cattle and sheep. With fewer doses needed and swift immunity onset, Syvazul BTV 3 is set to transform flock management and animal health practices.
Stay Updated!
As Virbac rolls out this cutting-edge vaccine, livestock producers can look forward to a safer, more efficient way to protect their herds. This promising innovation in animal care is a manufacturing milestone worth celebrating!